SAPA China Annual Conference, Chengdu, April 6-7

Opportunities and Challenges of China’s Biopharmaceutical Industry Development and SAPA-China 2023 Annual Conference

PRIMACYT’s Business Development Manager for Asia, Ruoxun Xiao, will attend and represent our company at the SAPA China Annual Conference. The convention will be held in Chengdu, on April 6-7. The Sino-American Pharmaceutical Professionals Association – China (SAPA-China) is organizing the meeting, which is hosted by Sichuan Shengjie Pharmaceutical. The conference will focus on the ecological system of China’s pharmaceutical and biotechnology development, strategies to promote drug innovation and cutting-edge science and technology. The meetings holds a series of activities such as high-level forums, special forums, project matching, financing promotion and enterprise exhibition.

The topics cover the entire ecological chain of biopharmaceutical product development, manufacturing, commercialization, international collaboration, financing and marketing. The contents include target research and development of innovative drugs; preclinical and clinical drug discovery. Of special interest are process development and manufacturing of small molecule chemistries and large molecule biologics. Other objectives are market access registration and filing, commercial marketing and sales, and generic drug development and manufacturing technologies.

It will be an international academic event that connects the entire pharmaceutical industry from source innovation, applied research, clinical, manufacturing and sales.

More than 3,000 scholars from the world’s top research institutions and leaders of large multinational pharmaceutical and biotechnology innovation enterprises will attend the meeting.

Ruoxun Xiao will discuss business opportunities with representatives from Chinese Pharmaceutical companies and research institutions.